Flagship Merges 3 Startups to Turn Cause and Effect Insights Into Novel Medicines

Flagship Pioneering unveiled Etcelera, a new startup formed by combining three of the firm’s portfolio companies. Etcelera’s approach to drug R&D focuses on “causal intelligence,” which Flagship defines as predicting and understanding cause and effect in biology. The post Flagship Merges 3 Startups to Turn Cause and Effect Insights Into Novel Medicines appeared first on…

Read More

A Déjà Vu Moment for Women’s Health Research

In this column for Nature, Alina Salganicoff reviews efforts to improve women’s health research during previous U.S. administrations that fell short of their promise and highlights the recommendations of a congressionally mandated committee aimed at improving women’s health research at the National Institutes of Health.

Read More